2-氨基-6-甲基-4,5,6,7-四氢-1-苯并噻吩-3-腈 | 42225-04-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 中文名称: 2-氨基-6-甲基-4,5,6,7-四氢-1-苯并噻吩-3-腈
• 中文别名: 2-氨基-6-甲基-4,5,6,7-四氢-1-苯并噻吩-3-甲腈；2-氨基-3-氰基-6-甲基-4,5,6,7-四氢-1-苯并噻吩
• 英文名称: 2-amino-6-methyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile
• 英文别名: 2-amino-4,5,6,7-tetrahydro-6-methylbenzo[b]thiophene-3-carbonitrile；2-Amino-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile
• CAS: 42225-04-7
• 化学式: C₁₀H₁₂N₂S
• mdl: MFCD00128282
• 分子量: 192.285
• InChiKey: VDMBPDMXBJUYMB-UHFFFAOYSA-N

物化性质

• 熔点：
  138-140 °C(Solv: 1,4-dioxane (123-91-1))
• 沸点：
  392.8±42.0 °C(Predicted)
• 密度：
  1.22±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  78
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn
• 安全说明：
  S36/37
• 危险类别码：
  R20/21/22
• 海关编码：
  2934999090
• 危险品运输编号：
  UN3276
• 危险性防范说明：
  P264,P280,P261,P271,P302+P352,P321,P332+P313,P362+P364,P305+P351+P338,P337+P313,P304+P340,P312,P403+P233,P405,P501
• 危险性描述：
  H315,H319,H335
• 储存条件：
  存储条件：2-8°C，避光，惰性气体环境中保存。

SDS

Name:	2-Amino-6-methyl-4 5 6 7-tetrahydro-1-benzothiophene-3-carbonitrile Material Safety Data Sheet
Synonym:
CAS:	42225-04-7

Section 1 - Chemical Product MSDS Name:2-Amino-6-methyl-4 5 6 7-tetrahydro-1-benzothiophene-3-carbonitrile Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
42225-04-7	2-Amino-6-methyl-4,5,6,7-tetrahydro-1-	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. May cause respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 42225-04-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 147 - 149 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H12N2S
Molecular Weight: 0

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 42225-04-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Amino-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 42225-04-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 42225-04-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 42225-04-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-6-甲基-4,5,6,7-四氢-1-苯并噻吩-3-腈 在 亚硝酸特丁酯 、 copper(ll) bromide 作用下， 以 乙腈 为溶剂， 反应 2.0h， 以72%的产率得到2-bromo-6-methyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile
  参考文献：
  名称：

  含有 2-(3',4',5'-三甲氧基苯胺基)-3,6-二取代-4,5,6,7-四氢噻吩并[2,3-c]吡啶支架的新型抗微管蛋白药物的合成与生物学评价

  摘要：

  基于 4,5,6,7-四氢噻吩并[2,3-c]吡啶和4,5,6,7-四氢苯并[b]噻吩分子骨架的两个新系列化合物，其特征在于存在3' ,4',5'-三甲氧基苯胺基部分和其 2-或 3-位的氰基或烷氧基羰基分别被设计、合成和评估对一组癌细胞系和选定的高活性化合物的抗增殖活性、抑制微管蛋白聚合和细胞周期效应。我们已经鉴定了 2-(3',4',5'-trimethoxyanilino)-3-cyano-6-methoxycarbonyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine 衍生物 3a 及其 6-乙氧羰基同系物 3b 作为新型抗增殖剂，可抑制癌细胞生长，对一组三种癌细胞系的 IC50 值范围为 1.1 至 4.7 μM。它们在微摩尔水平与微管蛋白的相互作用导致细胞在细胞周期的 G2/M 期积累并导致细胞凋亡。细胞凋亡研究发现，化合物3a和3b以剂量依赖

  DOI：

  10.3390/molecules25071690
• 作为产物：
  描述：

  4-甲基环己酮 、 丙二腈 在 吗啉 、 sulfur 作用下， 以 乙醇 为溶剂， 生成 2-氨基-6-甲基-4,5,6,7-四氢-1-苯并噻吩-3-腈
  参考文献：
  名称：

  叔羟基噻吩并[2,3- d ]嘧啶酮骨架的创新合成：邻氨基噻吩和羰基化合物串联反应的天然产物

  摘要：

  从邻氨基噻吩腈和羰基化合物的环缩合反应中发展出了一种简单的碱性促进剂串联协议，用于合成叔羟基天然样噻吩并[2,3- d ]嘧啶酮骨架。反应过程包括PDF转化和光催化氧化。该合成策略为具有动力学，热力学控制和六元环效应的叔羟基化噻吩并[2,3- d ]嘧啶酮结构的区域选择性构建提供了另一种方法。

  DOI：

  10.1016/j.tetlet.2016.04.088

文献信息

• [EN] PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION<br/>[FR] COMPOSÉS DE PYRAZOLE UTILES DANS LE TRAITEMENT D'UNE INFLAMMATION
  申请人：BIOLIPOX AB

  公开号：WO2006032851A1

  公开（公告）日：2006-03-30

  There is provided compounds of formula (I), wherein R1, R2, Ra and Rb have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.

  提供具有公式(I)的化合物，其中R1，R2，Ra和Rb的含义如描述中所述，以及药用可接受的盐，这些化合物在需要和/或要求抑制脂氧合酶（例如15-脂氧合酶）活性的疾病治疗中有用，特别是在治疗炎症方面。
• Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors
  作者：Brad E. Sleebs、George Nikolakopoulos、Ian P. Street、Hendrik Falk、Jonathan B. Baell

  DOI：10.1016/j.bmcl.2011.07.050

  日期：2011.10

  4-Aminobenzothieno[3,2-d]pyrimidines were previously identified in a high throughput screening campaign as LIMK1 inhibitors. Scaffold reversal led to the identification of a series of simple 5,6-substituted 4-aminothieno[2,3-d]pyrimidines with low micromolar inhibition of LIMK1.

  4-氨基苯并噻吩并[3,2- d ]嘧啶先前在高通量筛选活动中被鉴定为LIMK1抑制剂。支架逆转导致鉴定了一系列简单的5,6-取代的4-氨基噻吩并[2,3- d ]嘧啶，对LIMK1的抑制作用很小。
• Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation
  作者：Hong-Xu Xie、Juan Zhang、Yue Li、Jin-He Zhang、Shan-Kui Liu、Jie Zhang、Hua Zheng、Gui-Zhou Hao、Kong-Kai Zhu、Cheng-Shi Jiang

  DOI：10.1016/j.bioorg.2021.105236

  日期：2021.10

  α-Glucosidase inhibitors, which can inhibit the digestion of carbohydrates into glucose, are one of important groups of anti-type 2 diabetic drugs. In the present study, we report our effort on the discovery and optimization of α-glucosidase inhibitors with tetrahydrobenzo[b]thiophen-2-yl)urea core. Screening of an in-house library revealed a moderated α-glucosidase inhibitors, 5a, and then the following

  α-葡萄糖苷酶抑制剂是一类重要的抗2型糖尿病药物，可抑制碳水化合物消化为葡萄糖。在本研究中，我们报告了我们在发现和优化具有四氢苯并[ b ]噻吩-2-基)脲核心的α-葡萄糖苷酶抑制剂方面的努力。内部文库的筛选揭示了一种缓和的 α-葡萄糖苷酶抑制剂，5a，然后进行以下结构优化以获得更有效的衍生物。与亲本化合物5a (IC 50为 26.71 ± 1.80 μM) 和阳性对照阿卡波糖 (IC 50为 258.53 ± 1.27 μM)相比，大多数这些衍生物对 α-葡萄糖苷酶的抑制活性增加。其中，化合物8r (IC 50  = 0.59 ± 0.02 μM) 和8s (IC 50  = 0.65 ± 0.03 μM) 是最有效的抑制剂，并且表现出优于 α-淀粉酶的选择性。荧光猝灭实验证实了两种化合物与α-葡萄糖苷酶的直接结合。动力学研究表明，这些化合物是非竞争性抑制剂，这与分子对接结果一致，即化
• Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from <i>Mycobacterium tuberculosis</i>
  作者：Ankita Punetha、Huy X. Ngo、Selina Y. L. Holbrook、Keith D. Green、Melisa J. Willby、Shilah A. Bonnett、Kyle Krieger、Emily K. Dennis、James E. Posey、Tanya Parish、Oleg V. Tsodikov、Sylvie Garneau-Tsodikova

  DOI：10.1021/acschembio.0c00184

  日期：2020.6.19

  Mycobacterium tuberculosis (Mtb) is a versatile acetyltransferase that multiacetylates aminoglycoside antibiotics abolishing their binding to the bacterial ribosome. When overexpressed as a result of promoter mutations, Eis causes drug resistance. In an attempt to overcome the Eis-mediated kanamycin resistance of Mtb, we designed and optimized structurally unique thieno[2,3-d]pyrimidine Eis inhibitors toward

  结核分枝杆菌（Mtb）的增强的细胞内存活（Eis）蛋白是一种多功能的乙酰转移酶，可对氨基糖苷类抗生素进行多乙酰化，从而消除了与细菌核糖体的结合。当由于启动子突变而过表达时，Eis引起耐药性。为了克服Eis介导的Mtb的卡那霉素耐药性，我们设计并优化了结构独特的硫代[2,3- d ]嘧啶Eis抑制剂，以实现有效的卡那霉素佐剂联合治疗。我们获得了12种酶抑制剂复合物的晶体结构，这指导了我们合理的基于72 thieno [2,3- d]嘧啶类似物分为三个家族。我们评估了这些抑制剂在体外的效力，以及它们在抗性Mtb菌株中恢复卡那霉素活性的能力，其中Eis被上调。此外，我们评估了11种化合物的体外代谢稳定性。这项研究展示了结构信息如何指导Eis抑制剂的设计。
• An Efficient One-Pot Synthesis of Substituted 2-Aminothiophenes via Three-Component Gewald Reaction Catalyzed by l-Proline
  作者：Xiao-Yong Xu、Bu-Bing Zeng、Tao Wang、Xian-Gui Huang、Jia Liu、Bo Li、Jin-Jin Wu、Kai-Xian Chen、Wei-Liang Zhu

  DOI：10.1055/s-0029-1219917

  日期：2010.6

  An efficient one-pot procedure for the direct catalytic synthesisof substituted 2-aminothiophenes catalyzed by L-proline undermild reaction conditions has been developed. A variety of functionalized2-aminothiophene scaffolds were assembled in high yields by thiscatalytic protocol. Low catalyst loading, simple procedure, andhigh yields are the important attributes of this methodology.

  已开发出一种在温和反应条件下由 L-脯氨酸催化直接催化合成取代 2-氨基噻吩的有效一锅法。通过该催化方案以高产率组装了多种功能化的2-氨基噻吩支架。低催化剂负载、简单程序和高产率是该方法的重要属性。